Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India.
Padmapriyadarsini C, Ramesh Kumar S, Terrin N, Narendran G, Menon PA, Ramachandran G, Subramanyan S, Venkatesan P, Wanke C, Swaminathan S. Padmapriyadarsini C, et al. Among authors: ramesh kumar s. Clin Infect Dis. 2011 Feb 15;52(4):540-6. doi: 10.1093/cid/ciq195. Epub 2011 Jan 20. Clin Infect Dis. 2011. PMID: 21252141 Free PMC article. Clinical Trial.
Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.
Swaminathan S, Padmapriyadarsini C, Venkatesan P, Narendran G, Ramesh Kumar S, Iliayas S, Menon PA, Selvaraju S, Pooranagangadevi NP, Bhavani PK, Ponnuraja C, Dilip M, Ramachandran R. Swaminathan S, et al. Among authors: ramesh kumar s. Clin Infect Dis. 2011 Oct;53(7):716-24. doi: 10.1093/cid/cir447. Clin Infect Dis. 2011. PMID: 21890776 Clinical Trial.
Acquired rifampicin resistance in thrice-weekly antituberculosis therapy: impact of HIV and antiretroviral therapy.
Narendran G, Menon PA, Venkatesan P, Vijay K, Padmapriyadarsini C, Ramesh Kumar S, Bhavani KP, Sekar L, Gomathi SN, Chandrasekhar C, Kumar S, Sridhar R, Swaminathan S. Narendran G, et al. Among authors: ramesh kumar s. Clin Infect Dis. 2014 Dec 15;59(12):1798-804. doi: 10.1093/cid/ciu674. Epub 2014 Aug 25. Clin Infect Dis. 2014. PMID: 25156114 Clinical Trial.
4-month moxifloxacin containing regimens in the treatment of patients with sputum-positive pulmonary tuberculosis in South India - a randomised clinical trial.
Velayutham B, Jawahar MS, Nair D, Navaneethapandian P, Ponnuraja C, Chandrasekaran K, Narayan Sivaramakrishnan G, Makesh Kumar M, Paul Kumaran P, Ramesh Kumar S, Baskaran D, Bella Devaleenal D, Sirasanambati DR, Vasantha M, Palaniyandi P, Ramachandran G, Uma Devi KR, Elizabeth Hannah L, Sekar G, Radhakrishnan A, Kalaiselvi D, Dhanalakshmi A, Thiruvalluvan E, Raja Sakthivel M, Mahilmaran A, Sridhar R, Jayabal L, Rathinam P, Angamuthu P, Soorappa Ponnusamy K, Venkatesan P, Natrajan M, Prasad Tripathy S, Swaminathan S. Velayutham B, et al. Among authors: ramesh kumar s. Trop Med Int Health. 2020 Apr;25(4):483-495. doi: 10.1111/tmi.13371. Epub 2020 Feb 3. Trop Med Int Health. 2020. PMID: 31944502 Free article. Clinical Trial.
Role for Linezolid in drug sensitive tuberculosis.
Ramesh Kumar S, Narendran G, Padmapriyadarsini C. Ramesh Kumar S, et al. J Infect Public Health. 2024 Jan;17(1):172-174. doi: 10.1016/j.jiph.2023.11.012. Epub 2023 Nov 13. J Infect Public Health. 2024. PMID: 38039860 Free article. Review.
Permanent Anterior Teeth Fractures and its Impact on Oral Health-Related Quality of Life among 8-15-Year-Old Schoolchildren of Chennai City - A Cross-Sectional Survey.
Lakshmi KPD, Aswath Narayanan MB, Ramesh Kumar SG, Selvamary AL, Sujatha A. Lakshmi KPD, et al. Among authors: ramesh kumar sg. Int J Appl Basic Med Res. 2020 Jan-Mar;10(1):30-36. doi: 10.4103/ijabmr.IJABMR_346_18. Epub 2020 Jan 3. Int J Appl Basic Med Res. 2020. PMID: 32002383 Free PMC article.
14 results